Stay updated on Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing participating sites across Alabama, Arizona, California, Illinois, Indiana, Kansas, Michigan, Missouri, Ohio, Tennessee, and Utah, and removed prior state-location headings. The HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-24T15:35:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The Study Record Dates section now displays Last Update Posted (Estimated) and a new Revision: v3.3.2 label, while the previous labels Last Update Posted and Revision: v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-25T21:16:59.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Minor maintenance updates were made: upcoming dates were added (2025-11 and 2026-11-04) and a government funding lapse notice was removed. These changes do not affect the study details, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T19:04:03.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    No substantive changes to the study details; the screenshots show only minor layout/formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T23:04:57.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T13:49:26.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Page updated from v3.0.2 to v3.1.0; a specific term (Melanoma, Cutaneous Malignant) was removed. If core content and essentials are unchanged, this is a minor revision update with terminology pruning.
    Difference
    0.1%
    Check dated 2025-09-29T09:45:07.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.